Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Deciphering the role of BRCA1 during mammary differentiation through the study of mitotic spindle assembly
FY 2011-12
Summary
Breast cancer is not one disease. Many breast cancers express markers that tell us if they will respond to certain treatments. Some forms of breast cancer look like the normal cells in the breast, but others look abnormal. Women from some families have a high likelihood of developing breast cancer due to mutations in a gene called Breast Cancer 1 (BRCA1). These breast cancers will most likely not express the treatment markers, will not resemble normal breast cells, and will be reminiscent of primitive breast stem cells. We do not yet know why loss of BRCA1 function alters breast cell structure nor do we know how to fix this failure. We propose that BRCA1 activity is important for breast cell structure to allow for optimal growth. Another gene is known to block the action of BRCA1, suggesting that drugs that block this gene may be effectively used to stop the tumor formation. My project has two goals: to learn more about how BRCA1 may influence breast cell structure and to test new drugs to see if they can help cells with diminished BRCA1 function regain correct structure. To accomplish my goals, I will study laboratory-grown cells and measure their ability to form structures. I will reduce BRCA1 activity in these cells, using existing viral technologies, and measure the effect on growth and structure formation. Next, normal breast cells from surgically discarded human breast tissue will be assessed for their ability to form organized structures upon disruption of BRCA1 activity. Novel drugs will be tested, in attempt to correct defective tissue organization caused by suboptimal BRCA1 activity. In short, we will examine the role of BRCA1 in normal breast development and how deregulation of this process results in a breast cancer. This study carries great potential for improving personal and population health, as it will improve our understanding of factors involved in development of breast tumors, and will aid in the design of targeted anticancer protocols.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
253806
Name
Nemirovsky Oksana
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Deciphering the role of BRCA1 during mammary differentiation through the study of mitotic spindle assembly
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anticancer Therapeutics; Asymmetric Cell Division; Aurka Small Molecules Inhibitors; Brca1; Breast Cancer; Cellular Polarization; Confocal Microscopy; Facs Analysis/Sorting; Human Mammary Stem Cells; Lentiviral Transduction/Transfection
Abstract
Breast cancer is not one disease. Many breast cancers express markers that tell us if they will respond to certain treatments. Some forms of breast cancer look like the normal cells in the breast, but others look abnormal. Women from some families have a high likelihood of developing breast cancer due to mutations in a gene called Breast Cancer 1 (BRCA1). These breast cancers will most likely not express the treatment markers, will not resemble normal breast cells, and will be reminiscent of primitive breast stem cells. We do not yet know why loss of BRCA1 function alters breast cell structure nor do we know how to fix this failure. We propose that BRCA1 activity is important for breast cell structure to allow for optimal growth. Another gene is known to block the action of BRCA1, suggesting that drugs that block this gene may be effectively used to stop the tumor formation. My project has two goals: to learn more about how BRCA1 may influence breast cell structure and to test new drugs to see if they can help cells with diminished BRCA1 function regain correct structure. To accomplish my goals, I will study laboratory-grown cells and measure their ability to form structures. I will reduce BRCA1 activity in these cells, using existing viral technologies, and measure the effect on growth and structure formation. Next, normal breast cells from surgically discarded human breast tissue will be assessed for their ability to form organized structures upon disruption of BRCA1 activity. Novel drugs will be tested, in attempt to correct defective tissue organization caused by suboptimal BRCA1 activity. In short, we will examine the role of BRCA1 in normal breast development and how deregulation of this process results in a breast cancer. This study carries great potential for improving personal and population health, as it will improve our understanding of factors involved in development of breast tumors, and will aid in the design of targeted anticancer protocols.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nemirovsky, Oksana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~